Seventy-five patients attending a clinic for chronic prostatitis were evaluated by use of lower urinary tract localization cultures. Coagulase-negative staphylococci, alpha-hemolytic streptococci, and diphtheroids were the most common isolates, but none of these organisms were pathogens, based on Prostatitis is a common clinical problem. By one estimate half of all men experience symptoms of prostatitits at some time in their lives (16) . These symptoms cause significant morbidity and represent a major indication for diagnostic procedures, treatment with antimicrobial drugs or other medications, or surgical procedures (7, 11, 15) . This paper describes our experience with a standardized protocol for the evaluation of lower urinary tract localization (LUTL) specimens in a carefully defined patient population. Specific goals were to: (i) familiarize clinical microbiologists with techniques used to diagnose prostatitis syndromes, (ii) describe direct Gram stain quantitation of leukocytes in lower urogenital tract specimens, (iii) encourage identification and antimicrobial susceptibility testing of organisms that cause morbidity in men with prostatitis, and (iv) minimize the workup of aerobic bacteria that do not appear to be clinically significant.
MATERIALS AND METHODS
Patient population. All patients who attended a special urology clinic at University Hospital, Seattle, Wash., between 15 June 1984 and 31 December 1987 and who met the clinical criteria for chronic prostatitis were offered a comprehensive evaluation of their problem (including microbiological and structural causes). Of more than 100 patients seen, 75 elected to have the diagnostic evaluation described in this study. The two most common reasons why patients declined to undergo the evaluation were that they desired immediate treatment or that they wished to avoid uncomfortable procedures.
The mean age of the patients in ths study was 39.6 years (median, 38 years; range, 15 to 72 years). Seventy of the patients (93%) were heterosexual, and five (7%) were homoor bisexual. Thirty patients (40%) were married.
Definitions. A standard set of definitions was applied by the single urologist who evaluated all the patients.
(i) Chronic prostatitis. Patients were considered to have chronic prostatitis if they met three criteria: (i) the patient attended the specialized clinic for prostatitis, (ii) symptoms had persisted for at least 3 months, and (iii) the patient had been told that he had prostatitis and had been treated * Corresponding author.
previously by at least one physician. Patients with chronic prostatitis syndromes were further classified into three groups, chronic bacterial prostatitis, nonbacterial prostatitis, and prostatodynia, following the criteria described by Stamey and others (2, 11, 16) . Chronic bacterial prostatitis was defined as documented episodes of bacteriuria caused by the same bacterial species that were localized in the prostate. Nonbacterial prostatitis was defined as objective evidence of prostatic inflammation but no evidence of bacterial prostatitis. Prostatodynia was defined as symptoms but no evidence of either bacterial prostatitis or prostatic inflammation.
(ii) Inflammation. Inflammation was defined as .12 leukocytes per high-power field (hpf) (x400) of Gram-stained prostatic secretions (1, 16) .
(iii) Prostatic focus. A bacterial species was considered to be localized in the prostate if there was at least a 10-fold increase in CFU per milliliter between the first-void urine (VB1) specimen and the postmassage urine (VB3) specimen or the expressed prostatic secretions (EPS) if the VB3 specimen did not meet this criterion (11, 12, 16 (ài) Cultures and growth conditions. The urine was quantitatively cultured with 0.1-ml samples of urine each delivered by a micropipette to one entire heart infusion agar plate containing 5% defibrinated sheep blood (Difco Laboratories, Detroit, Mich.) and one entire MacConkey agar plate (without crystal violet) (10) . The EPS were cultured in an identical fashion, unless there was <0.1 ml, in which case 0.01-ml samples each were delivered by a micropipette to one entire blood agar plate and one entire MacConkey agar plate. The cultures were incubated at 35°C in an atmosphere of 10% C02 and examined after overnight incubation and again after an additional 18 to 24 h of incubation.
(iii) Identification and susceptibility testing. Colonies were Gram stained and biochemical properties were determined by standard methods (9) , by the AutoMicrobic system GNI card (Vitek Systems, Inc., Hazelwood, Mo.), and by the API 20E and Staph-Ident systems (Analytab Products, Plainview, N.Y.). Antimicrobial susceptibility was determined by the standardized disk diffusion method (13 CFU/ml in all of their LUTL cultures ( Table 1 ). The median counts were 800 CFU/ml for VB1, 80 CFU/ml for VB2, 500 CFU/ml for EPS, and 130 CFU/ml for VB3. The numbers of species isolated in aerobic LUTL cultures for the 75 patients with chronic prostatitis are summarized in Table 2 . Bacteria were isolated from VB1 in 60 cases (80%), from VB2 in 49 cases (65%), from EPS in 51 cases (68%), and from VB3 in all 75 cases. The median numbers of species isolated were two in VB1 and one each in VB2, EPS, and VB3. Coagulase-negative staphylococci, alpha-hemolytic streptococci, and diphtheroids were the most common isolates in all lower urinary tract specimens (Table 3) .
(ii) Organisms isolated from the prostate. Thirteen patients had prostatic localization of organisms; seven of these patients had recognized uropathogens and met the criteria for chronic bacterial prostatitis (Table 4) . Each of the seven had documented bacteriuria caused by the same organism that was localized in the prostate in subsequent LUTL studies. Organisms isolated included Escherichia coli in five cases and Pseudomonas aeruginosa and Enterobacter cloacae in one case each. Six patients had LUTL study results consistent with prostatic localization of organisms but without documented bacteriuria. The organisms isolated from this group have no proven pathogenic potential in the male genitourinary tract and included beta-hemolytic streptococci in two cases and alpha-hemolytic streptococci, coagulasenegative staphylococci (not Staphylococcus saprophyticus), lactobacilli, and diphtheroids in one case each (Table 4) . These organisms were isolated from five patients with prostatodynia and one patient with nonbacterial prostatitis.
Five additional patients had documented bacteriuria (>10,000 CFU/ml of VB2), but the organisms were not localized, so these patients did not meet the microbiological criteria for bacterial prostatitis in subsequent LUTL studies. The organisms isolated from these men included Enterococcus sps. in two cases and E. coli, Klebsiella pneumoniae, and S. saprophyticus in one case each. (iii) Inflammatory response. The seven patients with chronic bacterial prostatitis caused by recognized uropathogens had a mean of 44 leukocytes per hpf (median, 30; range, O to 100) of EPS. In contrast, the six patients who had other bacteria localized in the prostate but who had no history of bacteriuria had a mean of 4 leukocytes per hpf (median, 0; range, 0 to 20) of EPS (P = 0.0426; two-tailed t test).
Clinical classification of patients, treatment, and outcome.
Of the 75 patients with chronic prostatitis, 7 (9%) had chronic bacterial prostatitis, 8 (11%) had nonbacterial prostatitis, and 60 (80%) had prostatodynia. The seven patients with chronic bacterial prostatitis received 3 months of treatment with trimethoprim-sulfamethoxazole. Five were cured of infection, as determined by at least two subsequent localization studies after the completion of treatment. The other two patients remain asymptomatic on continuous, low dosages of antimicrobial drugs despite persistent prostatic foci of infection. Each of the five patients who had documented bacteriuria and who did not meet the criteria for bacterial prostatitis received a 7-to 10-day course of antimicrobial drugs, such as nitrofurantoin, that have poor penetration of uninflamed prostatic parenchyma. All responded well and had at least two negative localization studies following the completion of therapy. The six patients with other organisms localized in the prostate but with no evidence of bacteriuria received no treatment. Follow-up of three of these patients after 3 months showed that two estimated that their symptoms were at least 90% resolved. The remaining patient experienced transient improvement after discontinuing previous antimicrobial therapy, followed by a recurrence. Of the 75 patients, 14 had other organisms isolated (Chlamydia trachomatis, Trichomonas vaginalis, Ureaplasma urealyticum, and Mycoplasma hominis) and 8 had significant structural or functional abnormalities (Krieger and Egan, in preparation). There was no statistically significant difference in the prevalence of these organisms among the three patient groups.
DISCUSSION
Microbiological criteria for the classification of prostatitis syndromes were suggested by Meares and Stamey and others (2, 12) . These investigators proposed that patients with bacteriuria should be distinguished from those with no evidence of bacteriuria and that careful LUTL studies could be used to differentiate four syndromes: acute bacterial prostatitis, chronic bacterial prostatitis, nonbacterial prostatitis, and prostatodynia. Patients with bacterial prostatitis have (i) urinary tract infections caused by recognized uropathogens, (ài) objective evidence of prostatic inflammation, and (iii) a prostatic focus of infection.
Patients with acute bacterial prostatitis seldom pose major diagnostic or therapeutic problems (11, 16) . Acute bacterial prostatitis is characterized by the isolation of high colony counts of recognized uropathogens in the midstream urine from patients with a characteristic clinical syndrome. Clinical findings that suggest acute bacterial prostatitis include lower urinary tract irritative symptoms, such as urinary urgency and frequency, systemic signs and symptoms, and an abnormally tense prostate (7, 11, 16) . The causes and potentially life-threatening consequences of acute bacterial prostatitis are usually apparent, and patients respond dramatically to appropriate antimicrobial therapy.
In contrast to acute bacterial prostatitis, chronic prostatitis syndromes challenge both the clinician's diagnostic acumen and the resources of the clinical microbiology laboratory. These syndromes include chronic bacterial prostatitis, nonbacterial prostatitis, and prostatodynia. Chronic bacterial prostatitis is characterized by recurrent urinary tract infections caused by the same bacterial species. Patients are often asymptomatic between episodes of bacteriuria, seldom have abnormalities on physical examination, and require prolonged treatment with antimicrobial drugs. During the last 2 decades there have been many valuable studies of chronic bacterial prostatitis. These efforts have improved our understanding of both specific immunological factors and nonspecific host defenses of the male lower urogenital tract, such as pH and the prostatic antibacterial factor (3, 4, 6, 8, 14, 17) .
Of the 75 patients with chronic prostatitis in this study, 7 (9%) met the criteria for chronic bacterial prostatitis. Organ (7, 16) .
This study has three important implications for clinical microbiology laboratories. First, clear communication between physicians and laboratories is essential to ensure that optimal specimens are obtained, transported expeditiously, and appropriately handled in the laboratory. Laboratory personnel should understand the nature of the LUTL specimens and the clinical problem. LUTL procedures are uncomfortable, expensive, and time-consuming. Second, efforts should be directed toward the isolation and antimicrobial susceptibility testing of bacteria that have established pathogenic potential in the genitourinary tract. These organisms include members of the family Enterobacteriaceae, Enterococcus spp., P. aeruginosa, and S. saprophyticus. Antimicrobial therapy is optimally used to eliminate such uropathogens from men with bacterial prostatitis or documented bacteriuria. The total CFU per milliliter are much less important than the CPU of recognized uropathogens per milliliter (Table 4) . Third, determination of the species of organisms, such as coagulase-negative staphylococci other than S. saprophyticus, alpha-hemolytic streptococci, diphtheroids, and similar bacteria, isolated from the male lower urinary tract probably represents a poor use of laboratory resources. The information is seldom useful for patient management and may be misleading. Antimicrobial susceptibility testing of such organisms may be interpreted as an indication for the treatment of organisms with minimal pathogenic potential. Our experience is that patients with symptoms of chronic prostatitis receive many unsuccessful courses of antimicrobial drugs (7, 16) . Optimal use of clinical laboratory resources can be achieved by emphasizing identification and antibiotic susceptibility testing of recognized uropathogens.
